Visual Acuity Outcome over Time in Non-Infectious Uveitis

Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Research Group

Research output: Contribution to journalArticle

Abstract

Introduction: We evaluated visual acuity (VA) over 5 years in a subspecialty noninfectious uveitis population. Methods: Retrospective data from 5,530 noninfectious uveitis patients with anterior, intermediate, posterior or panuveitis were abstracted by expert reviewers. Mean VA was calculated using inverse probability of censoring weighting to account for losses to follow-up. Results: Patients were a median of 41 years old, 65% female, and 73% white. Initial mean VA was worse among panuveitis (20/84) than posterior (20/64), intermediate (20/47), and anterior (20/37) uveitides. On average, mean VA improved by 0.62, 0.51, 0.37, and 0.26 logMAR-equivalent lines over 2 years, respectively (each P <.001), then remained stable, except posterior uveitis mean VA worsened to initial levels. Conclusion: Mean VA of uveitic eyes improved and, typically, improvement was sustained under uveitis subspecialty care. Because VA tends to improve under tertiary care, mean VA change appears a better outcome for clinical studies than time-to-loss of VA.

Original languageEnglish (US)
JournalOcular Immunology and Inflammation
DOIs
StateAccepted/In press - Jan 1 2019

    Fingerprint

Keywords

  • inverse probability of censoring weighting
  • Uveitis
  • Visual acuity

ASJC Scopus subject areas

  • Immunology and Allergy
  • Ophthalmology

Cite this

Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Research Group (Accepted/In press). Visual Acuity Outcome over Time in Non-Infectious Uveitis. Ocular Immunology and Inflammation. https://doi.org/10.1080/09273948.2019.1687733